The cascade of care for hepatitis B – any lessons from the HIV field?
- Published on 09/12/2025
- Reading time: 1 min.
Vicente Soriano a,* , Víctor Moreno-Torres a,b , Pablo Barreiro c , Carmen Álvarez a , Octavio Corral a & Carmen de Mendoza b
a UNIR Health Sciences School, Universidad Internacional de La Rioja (UNIR), Madrid, Spain
b Department of Internal Medicine, Puerta de Hierro University Hospital, Madrid, Spain
c Department of Internal Medicine, Hospital Carlos III-La Paz University Hospital, Madrid, Spain
CONTACT Vicente Soriano mailto:vicente.soriano@unir.net UNIR Health Sciences School, Universidad Internacional de La Rioja (UNIR), c/García Martín 21, Pozuelo 28224, Spain
Abstract
Introduction HIV and hepatitis B continue to be global public health challenges. Each virus causes 1.2 million new infections annually. By 2025, roughly 40 million people live with HIV, and over 250 million have chronic hepatitis B.
Areas covered Using PubMed, we analyzed approaches to control HIV and HBV epidemics. Whereas no vaccine exists to prevent HIV acquisition, successful protective HBV vaccines are available. The high incidence of HBV is largely...
To continue reading this article in Full-Text...
Search | Advanced search
Articles by topics
